Impact of gout on in-hospital outcomes of acute coronary syndrome-related hospitalizations and revascularizations: Insights from the national inpatient sample

doi:10.4330/wjc.v11.i5.137

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7930)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

591

WORD

178

HTML

4427

Tables (1-5)

238

Sum=5434

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

915

Download

1581

Sum=2496

May 26, 2019 (publication date) through Nov 6, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Cardiol. May 26, 2019; 11(5): 137-148
Published online May 26, 2019. doi: 10.4330/wjc.v11.i5.137

Table 4 Post-revascularization (percutaneous coronary intervention or coronary artery bypass grafting) complications in acute coronary syndrome patients with vs without gout

Complications	No gout(n = 1592156)	Gout(n = 47307)	P value
All-cause in-hospital mortality	47466 (3.0)	1038 (2.2)	< 0.001^a
Hemorrhage	43541 (2.7)	1470 (3.1)	< 0.001^a
Blood transfusion	12272 (0.8)	524 (1.1)	< 0.001^a
Hypotension/shock	7319 (0.5)	261 (0.6)	0.004^a
Cardiac complications	46511 (2.9)	1523 (3.2)	< 0.001^a
Postoperative myocardial infarction	27176 (1.7)	798 (1.7)	0.74
Stroke	3926 (0.2)	140 (0.3)	0.033^a
Respiratory complications	46531 (2.9)	1642 (3.5)	< 0.001^a
Gastrointestinal complications	25573 (1.6)	980 (2.1)	< 0.001^a
AKI requiring dialysis	7843 (0.5)	628 (1.3)	< 0.001^a
Urinary complications	4641 (0.3)	307 (0.6)	< 0.001^a
Post procedural infections	24473 (1.5)	687 (1.5)	0.139

^aP < 0.05 indicates clinical significance. ACS: Acute coronary syndrome; PCI: Percutaneous coronary intervention; CABG: Coronary artery bypass grafting; AKI: Acute kidney injury.

Citation: Desai R, Parekh T, Goyal H, Fong HK, Zalavadia D, Damarlapally N, Doshi R, Savani S, Kumar G, Sachdeva R. Impact of gout on in-hospital outcomes of acute coronary syndrome-related hospitalizations and revascularizations: Insights from the national inpatient sample. World J Cardiol 2019; 11(5): 137-148
URL: https://www.wjgnet.com/1949-8462/full/v11/i5/137.htm
DOI: https://dx.doi.org/10.4330/wjc.v11.i5.137